drugset / Trial / NCT00051155
A 6-Week Safety and Efficacy Study of Travatan Compared to Xalcom in Subjects With Open-Angle Glaucoma(OAG) or Ocular Hypertension(OHT)
RandomizedParallel-groupDouble-blindTreatment
Summary
To compare the safety and IOP-lowering efficacy of TRAVATAN and XALCOM in subjects with open-angle glaucoma or ocular hypertension.
Timeline
- Start
- 2001-01
- Primary completion
- 2004-07
- Completion
- 2004-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Latanoprost | Small molecule | 0.005 % | — |
| Subject | Timolol | Other / unclassified | 0.5 % | — |
| Subject | Travoprost | Other / unclassified | 0.004 % | — |